OSRX®

OSRX® is a PCAB-accredited compounding pharmacy based in Missoula, Mont. The company specializes in compounding quality ophthalmic formulations. OSRX® focuses on customizing compounded medications to meet unique patient and practitioner needs. It's important to note that compounded drugs are not FDA-approved, meaning they have not undergone FDA premarket review for safety, effectiveness, and quality. OSRX® was founded in 2019 and is headquartered in the United States. As of now, there is no publicly available information regarding their last investment or the investors involved. Overall, OSRX® presents an intriguing value proposition with its focus on compounding ophthalmic medications. However, the lack of information regarding their last investment and investors could raise questions about their funding and growth trajectory. It will be crucial for potential investors to dive deeper into OSRX®'s financial history and current funding status before considering any investment opportunities. Additionally, given the regulatory considerations around compounded drugs, it will be essential for investors to assess the company's compliance and risk management strategies in relation to FDA regulations.